Expectant management of severe preeclampsia remote from term: hope for the best, but expect the worst

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 3, 2008, Pages 209-212

  Norwitz, Errol R ^a   Funai, Edmund F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

BLOOD CLOTTING DISORDER; BLOOD PRESSURE MONITORING; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL BLINDNESS; CORTICOSTEROID THERAPY; CYANOSIS; DISEASE SEVERITY; ECLAMPSIA; EDITORIAL; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LIVER INJURY; LIVER RUPTURE; LUNG EDEMA; OLIGURIA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; STROKE; THROMBOCYTOPENIA;

ADULT; FEMALE; HUMANS; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK;

EID: 50349100357     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.084     Document Type: Editorial

References (21)

1. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia: ACOG Practice Bulletin No.: 33. Obstet Gynecol 99 (2002) 159-167
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
3. Schiff E., Friedman S.A., Kao L., and Sibai B.M. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 175 (1996) 1313-1316
4. Hall D.R., Odendaal H.J., Steyn D.W., and Grive D. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynaecol Obstet 77 (2002) 1-6
5. Chammas M.F., Nguyen T.M., Li M.A., Nuwayhid B.S., and Castro L.C. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 183 (2000) 853-858
6. Odendaal H.J., Pattinson R.C., Bam R., Grove D., and Kotze T.JvW. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 76 (1990) 1070-1074
7. Sibai B.M., Mercer B.M., Schiff E., and Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
8. Magann E.F., Bass D., Chauhan S.P., Sullivan D.L., Martin R.W., and Martin Jr. J.N. Antepartum corticosteroids: disease stabilization in patients with the syndrome hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171 (1994) 1148-1153
9. Isler C.M., Barrilleaus P.S., Magann E.F., Bass J.D., and Martin Jr. J.N. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 184 (2000) 1332-1337
10. Bombrys A.E., Barton J.R., Nowacki E., et al. Expectant management of severe preeclampsia at <27 weeks gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol (2008) [In press.]
11. Sibai B.M., Taslimi M., Abdella T.N., Brooks T.F., Spinnato J.A., and Anderson G.D. Maternal and perinatal outcome of conservative management of severe preeclampsia in mid trimester. Am J Obstet Gynecol 152 (1985) 32-37
12. Pattinson R.C., Odendaal H.J., and du Toit R. Conservative management of severe proteinuric hypertension before 28 week's gestation. S Afr Med J 73 (1988) 516-518
13. Sibai B.M., Akl S., Fairlie F., and Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 163 (1990) 733-738
14. Moodley J., Koranteng S.A., and Rout C. Expectant management of early onset of severe preeclampsia in Durban. S Afr Med J 83 (1993) 584-587
15. Hall D.R., Odendaal H.J., and Steyn D.W. Expectant management of severe pre-eclampsia in the mid-trimester. Eur J Obstet Gynecol Reprod Biol 96 (2001) 168-172
16. Vigil-De Gracia P., Montufar-Rueda C., and Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 107 (2003) 24-27
17. Haddad B., Deis S., Goffinet F., et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 190 (2004) 1590-1597
18. Shear R.M., Rinfret D., and Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?. Am J Obstet Gynecol 192 (2005) 1119-1125
19. Gaugler-Senden I.P., Huijssoon A.G., Visser W., Steegers E.A., and de Groot C.J. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation: audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 128 (2006) 216-221
20. Budden A., Wilkinson L., Buksh M.J., and McCowan L. Pregnancy outcome in women presenting with pre-eclampsia at less than 25 weeks gestation. Aust N Z J Obstet Gynaecol 46 (2006) 407-412
21. Sezik M., Ozkaya O., Sezik H.T., and Yapar E.G. Expectant management of severe preeclampsia presenting before 25 weeks of gestation. Med Sci Monit 13 (2007) 523-527